Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors38
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer27
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy26
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance24
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy22
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy22
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks21
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors20
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin19
Exosome as a Natural Gene Delivery Vector for Cancer Treatment18
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer17
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy16
Antibody-drug Conjugate Targets, Drugs, and Linkers16
Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process15
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent15
0.056747913360596